Swedish pharmaceutical firm receives major investment
Camurus, a pharmaceutical company specialising in developing innovative specialty medicines based in Lund, receives half a billion SEK (54 million EUR) investment from various investors, writes 8till5. The company recently announced a rights issue on Stockholm stock exchange, Nasdaq. Among the investors are Martin Gren, founder of Axis, and Erik Paulsson, founder of Peabs. With […]